Dr. Henry is a physician–scientist specializing in the clinical development of AAV gene therapies for rare and ultra-rare disorders, with experience guiding complex pediatric programs from preclinical translation through IND submission and clinical development. Most recently, he served as Medical Director of the Cell and Gene Therapy Center of Excellence at IQVIA, where he led medical strategy for global gene therapy programs across multiple indications. He has authored more than 400 peer-reviewed publications and has been recognized among the World’s Top 2% Scientists (Stanford/Elsevier) and as a Clarivate Highly Cited Researcher.